Tag Archives: glucagon

Many people with type 1 diabetes live with the constant fear of blood glucose dropping too low. Even today’s most advanced automated insulin delivery systems cannot actively raise glucose once levels begin to fall. Instead, they can only reduce or suspend insulin delivery. A dual-hormone artificial pancreas system changes that …

For years, glucagon-like peptide-1 (GLP-1) receptor agonists have dominated conversations about diabetes and obesity treatment. However, another hormone is quietly returning to the spotlight. Amylin diabetes therapy is making a comeback as researchers develop a new generation of drugs designed to improve blood glucose control and support weight management. Amylin …